Dr. Pradeep G. Bhide is the Jim and Betty Ann Rodgers Eminent Scholar Chair of Developmental Neuroscience and the director of the Center for Brain Repair at the Florida State University College of Medicine.
Dr. Bhide received his degree in veterinary medicine from Veterinary College, Bangalore, India, and a Ph.D. in neuroscience from the University of Aberdeen, Scotland. He undertook postdoctoral training in developmental neurobiology at University College, London; Yale University; and Massachusetts General Hospital and Harvard Medical School.
Director, Interdepartmental Neuroscience Center, Massachusetts General Hospital, Boston, MA (2003-11)
Vice Chair for Neurology Research, Massachusetts General Hospital, Boston, MA (2007-11)
Director, Center for Brain Repair, FSU College of Medicine (2011-present)
Scientific Review Committees
MDCN 7 (1999)
BDCN 2 (2003-4)
BDCN 4 (2003)
NCF/MDCN 6 (2004;2006-07)
ZNS1-SRB-E (2005-06; NINDS Program Project)
ZNS1-SRB-M34 (2006-7, NINDS Fellowships)
NINDS-NSD-B (2006; NINDS-Program Projects)
VA Center of Excellence (2009)
Neurogenesis and Cell Fate Study Section: Regular Member, 7/1/2008 – 6/30/2012
Autism Speaks, Research Grant Review Committee (2011)
MGH Subcommittee on Review of Research Proposals (2003-11)
Scientific Advisory Board National Parkinson Foundation, 2006-2008
Senior Editor, Developmental Neuroscience (2009-present)
Editorial Board - Developmental Neuroscience (2005-present)
Editorial Board: Current Neuropharmacology (2009-present)
Reviewing Editor, Frontiers in Neurogenesis (2009-present)
The research in the Bhide laboratory focuses on developmental neurological and psychiatric conditions including ADHD and early-onset generalized dystonia. Another area of research focus is the neurological and cognitive effects of prenatal and early postnatal exposure to prescription and illicit drugs.
Current research projects include examination of the role of dopamine receptor activation in the developing brain; the effects of prenatal exposure to cocaine, nicotine and analgesic medications on the development of the brain and behavior; and the developmental origins of the movement disorder generalized dystonia.
Dr. Bhide’s laboratory employs a variety of technologies including microscopy, histology, biochemistry and molecular biology, cell and tissue culture, neuropharmacology, and behavioral analysis.
Amber Brown, Ph.D.
Kevin Lee, B.S.
Deirdre McCarthy, B.S.
Lin Zhang, M.D., Ph.D.
Jinmin Zhu, M.D., Ph.D.
Biederman J, Petty CR, Bhide PG, Woodworth KY, Faraone S (2012) "Does exposure to maternal smoking during pregnancy affect the clinical features of ADHD? Results from a controlled study." The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 13:60-64.
McCarthy D, Bhide PG (2012) "Prenatal cocaine exposure decreases parvalbumin immunoreactive neurons and GABA-to-Projection neuron ratio in the medial prefrontal cortex." Dev Neurosci In Press.
McCarthy DM, Zhang X, Darnell SB, Sangrey GR, Yanagawa Y, Sadri-Vakili G, Bhide PG (2011) "Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain." J. Neurosci 31:13400-13411.
Ren JQ, Jiang Y, Wang Z, McCarthy D, Rajadhyaksha AM, Tropea TF, Kosofsky BE, Bhide PG (2011) "Prenatal l-DOPA exposure produces lasting changes in brain dopamine content, cocaine-induced dopamine release and cocaine-conditioned place preference." Neuropharmacology 60:295-302.
Zhu J, Spencer TJ, Liu-Chen LY, Biederman J, Bhide PG (2011) "Methylphenidate and mu opioid receptor interactions: a pharmacological target for prevention of stimulant abuse." Neuropharmacology 61:283-292.
Zhu J, Zhang X, Xu Y, Spencer T, Biederman J, Bhide PG (2012) "Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover and responsiveness to oral methylphenidate treatment." J Neurosci 32: 9410-8.